Slate Path Capital as of Dec. 31, 2019
Portfolio Holdings for Slate Path Capital
Slate Path Capital holds 26 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Snap Inc cl a (SNAP) | 12.9 | $239M | 15M | 16.33 | |
| Charter Communications Inc New Cl A cl a (CHTR) | 10.0 | $185M | 381k | 485.08 | |
| Barrick Gold Corp (GOLD) | 9.8 | $182M | 9.8M | 18.59 | |
| Bausch Health Companies (BHC) | 9.0 | $167M | 5.6M | 29.92 | |
| New York Times Company (NYT) | 8.5 | $159M | 4.9M | 32.17 | |
| Zillow Group Inc Cl C Cap Stk (Z) | 7.2 | $134M | 2.9M | 45.94 | |
| Kirby Corporation (KEX) | 7.2 | $134M | 1.5M | 89.53 | |
| Mosaic (MOS) | 7.1 | $132M | 6.1M | 21.64 | |
| Alnylam Pharmaceuticals (ALNY) | 5.1 | $94M | 815k | 115.17 | |
| Freeport-McMoRan Copper & Gold (FCX) | 4.9 | $92M | 7.0M | 13.12 | |
| Pan American Silver Corp Can (PAAS) | 4.6 | $85M | 3.6M | 23.69 | |
| Medicines Company | 3.7 | $70M | 818k | 84.94 | |
| EQT Corporation (EQT) | 2.9 | $54M | 5.0M | 10.90 | |
| Sibanye Gold | 2.1 | $39M | 3.9M | 9.93 | |
| Reata Pharmaceuticals Inc Cl A | 1.3 | $25M | 120k | 204.43 | |
| iShares MSCI Emerging Markets Indx (EEM) | 0.8 | $15M | 333k | 44.87 | |
| Cue Biopharma (CUE) | 0.8 | $14M | 890k | 15.88 | |
| Uniqure Nv (QURE) | 0.5 | $10M | 140k | 71.66 | |
| Zillow Group Inc Cl A (ZG) | 0.5 | $8.5M | 185k | 45.74 | |
| Intelsat Sa | 0.4 | $7.7M | 1.1M | 7.03 | |
| Lexinfintech Hldgs (LX) | 0.2 | $3.1M | 225k | 13.89 | |
| First Majestic Silver Corp (AG) | 0.1 | $2.1M | 170k | 12.26 | |
| Tidewater (TDW) | 0.1 | $2.1M | 110k | 19.28 | |
| Blue Apron Hldgs Inc Cl A | 0.1 | $2.1M | 320k | 6.58 | |
| Endo International (ENDPQ) | 0.1 | $1.6M | 350k | 4.69 | |
| United States Steel Corporation (X) | 0.0 | $456k | 40k | 11.40 |
